Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: James Lim, George Church, David Walt, Kevin Chen, More

James Lim

Syapse has hired James Lim as senior VP of product development. In this role, he will head up development of Syapse's precision medicine platform, primarily for cancer patients. Lim is a former executive VP of product and engineering at Internet of Things technology developer Enlightened, a company acquired by Siemens in May.


George Church, David Walt, Kevin Chen

Molecular diagnostics firm NuProbe Global has formed a scientific advisory board and appointed a new member to its board of directors. The firm has named George Church and David Walt as members of the scientific board. Church and Walt are currently professors of genetics and pathology, respectively, at Harvard Medical School. The firm has also appointed Kevin Chen, founding partner at Biotrack Capital, as a member of the board of directors. Chen has previously led investment in healthcare companies including Beijing Genomics Institute (BGI), Betta Pharma, and Yuwell Medical.


Alex Dickinson, Robert Proulx

Alex Dickinson and Robert Proulx have joined the board of directors of Quantapore.

Dickinson is currently founder and executive chairman of molecular diagnostics firm ChromaCode. Previously, he was a senior VP at Illumina, and prior to that, the founder and CEO of molecular diagnostics firm Helixis, which Illumina acquired in 2010. Earlier, he was the founder and CEO of Luxtera, which provides silicon photonics products. Dickinson holds a PhD from the University of Adelaide in Australia and an MBA from Columbia University.

Proulx is executive chairman and CEO of Imagion Biosystems, a medical imaging company. He was previously president of Silicon Biosystems, which was acquired by the Menarini Group. Proulx also held executive positions at Nanogen, Gene Logic, Igen, and Packard Bioscience. Proulx holds MA and BA degrees from the State University of New York at Albany and an executive MBA from the Penn State Smeal College of Business.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.